← Open Payments lookup

DAVID QUARLES: Open Payments

NPI 1235436577 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,049 in 41 payments from 14 companies in 2025. Trend: 2023 $533 · 2024 $2,713 · 2025 $1,049

Food & beverage: $1,049
CompanyPaymentsAmount
Madrigal Pharmaceuticals11$356
Ipsen Biopharmaceuticals, Inc6$179
ABBVIE INC.4$151
Phathom Pharmaceuticals, Inc.9$102
Fujifilm Healthcare Americas Corporation1$47
Novo Nordisk Inc2$34
Ardelyx, Inc.1$32
QOL Medical, LLC1$23
Takeda Pharmaceuticals U.S.A., Inc.1$22
Aimmune Therapeutics, Inc.1$22

Products named: REZDIFFRA, IQIRVO, RINVOQ, VOQUEZNA, UTASWAKO AFP-L3, DUPIXENT, Saxenda, IBSRELA.

Industry payments across MS — which companies pay providers there.